-
Identification and characterization of anti-prionic compounds that disassemble Tau prions as a novel therapeutic approach for tauopathies
-
Identification and characterization of anti-prionic compounds that disassemble αSyn prions as a novel therapeutic approach for synucleinopathies
-
Identification and clinical characteristics of Mild Cognitive Impairment in Parkinson’s disease
-
Identification and Documentation of Delirium in Parkinson’s Disease
-
Identification of a novel XK mutation in a Chinese patient with McLeod Syndrome
-
Identification of Factors that Impact Adherence to OnabotulinumtoxinA Treatment for Spasticity in Post-Stroke and Multiple Sclerosis Patients from ASPIRE
-
Identification of Parkinson’s disease predisposition genes in high-risk pedigrees
-
Identifying biomarkers to predict disease progression in early stage Parkinson’s disease patients
-
Identifying de novo Parkinson’s disease with optical coherence tomography of the retina: A machine learning classification approach
-
Identifying neural signatures of Parkinson’s disease that predict decline in gait and postural control
-
Identifying Neuropsychiatric Profiles in Parkinson’s disease, Dementia with Lewy Bodies and Alzheimer’s disease
-
Identifying the functional brain network of motor reserve in early Parkinson’s disease
-
Idiopathic cervical dystonia – does autoimmunity play a hand?
-
Idiopathic Upper Limb Dystonia – Time for a better understanding
-
Impact of Chronotypes and melatonin levels on sleep disorders in patients with Parkinson’s disease
-
Impact of community boxing program on motor impairments of Parkinson’s Disease (PD) including: gait, functional mobility, dual task and coordination
-
Impact of Deep Brain Stimulation on Fall Risk
-
Impact of dopamine 2/3 receptor agonists on the phenomenology of L-DOPA-induced dyskinesia in patients with Parkinson’s disease
-
Impact of Obstructive Sleep Apnea on Cognitive and Motor Functions in Parkinson’s Disease Patients
-
Impact of safinamide on non-motor and motor experiences of daily living: Primary results from the prospective, observational ProGo study
-
Impact of STN DBS on a musculoskeletal problem: A case report
-
Impaired inhibitory control of saccadic eye movements in cervical dystonia: an eye tracking study
-
Impaired Structural Connectivity in Parkinson’s Disease and its Neuropsychological Correlates
-
Impairment of the mesocortical dopamine system in Parkinson’s disease patients with freezing of gait in a multimodal imaging approach
-
Impedance Doesn’t Change with Levodopa Treatment
-
Implementation of an online, interactive curriculum in movement disorders at nine neurology residency programs
-
Implementation of computer game technologies for patients with ataxia due to post-traumatic head injury: Randomized controlled trial
-
Implementation of the ParkinsonNet care concept shows better expertise and work satisfaction of health professionals, but improvement of multidisciplinary collaboration takes longer than one year
-
Implementing a change of approach: From mono- to interdisciplinary follow-up of patients with PD
-
Improved Severe Complex Idiopathic Adult Onset Truncal Dystonia with Axial Twisting by Bilateral Pallidal Stimulation: Case Report
-
Improved verb use in Parkinson’s disease following intensive voice treatment
-
Improvement for Gait Disorders in Parkinson’s Disease Through Novel Comprehensive Treatment (IMPROVE study): A Prospective, Open-label, Randomized Controlled Clinical Trial
-
Improvement in the handicap is maintained after 5 years of deep brain stimulation in Parkinson’s disease
-
Improving automaticity of walking in Parkinson’s disease: Levodopa or Donepezil?
-
Improving Diagnosis and Treatment of Anxiety in Parkinson’s Disease: IDATA-PD Study Update
-
Improving estimation of Parkinson’s disease risk – enhancing the PREDICT-PD algorithm
-
Improving fall prediction in Parkinson’s disease: A machine-learning-based approach
-
Improving Hospital Outcomes through the Aware in Care Ambassador Program
-
Improving person – centered healthcare pathway organization for people with Parkinson’s disease, using Article 51.
-
Impulse Control Behaviours in People with Parkinson’s Disease: Findings from the Parkinson’s Disease Real-World Impact Assessment (PRISM) Study
-
Impulse control disorder and ventral striatum dopamine D3 receptor availability in Parkinson’s disease
-
Impulse control disorder in the patients of Parkinson’s disease: Various correlations
-
Impulse Control Disorders and Other Psychiatric Complications in a Series of Patients Treated Levodopa-Carbidopa Instestinal Gel
-
Impulse control disorders in Parkinson’s disease: A whole brain morphometric and diffusion tensor study
-
Impulsive Control Behaviours in Patients with GBA, PARK2 and without Mutations in Genes Associated to Parkinson’s Disease
-
Impulsivity and Compulsivity in Cerebellar Ataxias
-
IMU-based study on Gait and Balance in Parkinson´s disease and healthy subjects
-
In vivo imaging of presynaptic terminal loss in early Parkinson’s disease
-
In vivo markers of anxiety in drug-naïve Parkinson’s disease
-
Incidence and survival of psychosis in patients with Parkinson’s Disease (1991-2010)
-
Incidence of essential tremor depending on gender, age and debut of the disease
-
Incidence of Hip Fracture in People with Parkinson’s Disease at the Tertiary Care Hospital
-
IncobotulinumtoxinA to treat sialorrhea in Parkinson’s disease: A real-life study
-
Increased attention for food stimuli as a mechanism for weight gain in patients with Parkinson’s disease undergoing DBS of the subthalamic nucleus
-
Increased availability of the metabotropic glutamate receptor 5 in the motor system of patients with Parkinson’s disease
-
Increased epinephrine in the saliva of Parkinson’s disease patients: A preliminary observation
-
Increased expression of conexin 36 in rodent model of Parkinson disease
-
Increased illusory responses in non-hallucinating, cognitively impaired Lewy body disease patients
-
Increased neurofilament light chain plasma levels as a biological marker of mild cognitive impairment in Parkinson’s disease
-
Increased risk of Parkinson’s disease in patients with schizophrenia spectrum disorders
-
Increased Syllable Duration as a Marker for Dysarthria in Essential Tremor Patients with Deep Brain Stimulation
-
Indication and long-term outcome of device-aided therapies in advanced Parkinson’s disease
-
Inertial sensor-based kinematics in the differential diagnosis of Parkinson’s disease and atypical parkinsonisms
-
Inertial-sensor based full-body kinematics reveals an unstable gait with increased variability in patients with evidence of dopaminergic denervation with 123I-FP-CIT SPECT
-
Influence of emotion-affective apathy in theory of mind in Parkinson’s disease patients
-
Influencing factors when living with Parkinson’s disease: beyond the disease symptomatology
-
Information processing components in Parkinson’s disease with and without impulse control disorders: identification of diagnostic and predisposition markers
-
Inhaled levodopa (LD) as a treatment for Parkinson’s disease (PD) patients in an emergency setting
-
Initial Results from the Zambian Epidemiology of Parkinson’s disease and Healthcare Registry (ZEPHyR)
-
Inosine 5′-Monophosphate to Raise the Serum Uric Acid Level in Patients with Multiple System Atrophy (IMPROVE-MSA study): A Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Assigned Clinical Trial
-
Insomnia may have a mediating role in linking Parkinson’s disease severity to depression and anxiety
-
Instrumented Detection of Fluctuations with Wearable Devices in Parkinson’s Disease
-
Intact organization of tactile space in isolated focal dystonia
-
Inter-network connectivity dynamics underlie compensatory mechanisms in prodromal Parkinson’s disease
-
Inter-relation between hand functioning, cognition and quality of life of CP children: 2-year prospective randomized study
-
Interaction between genetic variants and serum levels of organochlorine pesticides contributes to Parkinson’s disease
-
Interest of multiplex ligation-dependent probe amplification assay to identify pathogenic mutations in Parkinson’s disease patients
-
Interim Analysis of Electrode Position and Motor Outcomes at 6 Months in STN-DBS for Parkinson’s Disease
-
Interpretation of health-related quality of life outcomes from the EARLYSTIM Study
-
Interrater Agreement for Movement Disorder Classification in Children with Mixed Movement Disorders
-
Intestinal Methanogen Overgrowth (IMO) More Prevalent than SIBO in Parkinson’s disease with Constipation: Preliminary Results
-
Intestinal transit in early-moderate Parkinson’s disease correlates with probable RBD – subclinical esophageal dysmotility does not correlate
-
Intracranial Tuberculous Abcess with Acute Parkinsonism: Unusual Finding
-
Intraoperative test objectively for discovering optimal electrode site for effective imaging (by eye) and bilateral STN-DBS stereotactic functional neurosurgery
-
Intraparenchymal Cyst Formation and Spontaneous Regression following Deep Brain Stimulation Surgery
-
Intrastriatal injection of alpha-synuclein preformed fibrils results in cognitive dysfunction and L-DOPA reversible sensorimotor impairments in rats
-
Intravenous Immunoglobulin Treatment did not improve Tics in a Patient with Gilles de la Tourette Syndrome and intrathecal Antibody Synthesis
-
Intrinsic brain functional connectivity predicts treatment-related motor complications in drug-naive Parkinson’s disease patients
-
Intrinsic Remodeling of the Fovea is Correlated with Contrast Sensitivity Loss in Parkinson’s Disease
-
Investigating Factors Contributing to Parkinson’s disease-related Cognitive Decline
-
Investigating Substantia Nigra Damage using Fully Automated Segmentation of Neuromelanin MRI in Early Parkinson’s Disease
-
Iron Imaging as a Diagnostic Tool for Parkinson’s Disease: A Systematic Review and Meta-Analysis
-
Is acoustic speech analysis applicable for evaluation of swallowing impairment in patients with Parkinson’s disease (PD)?
-
Is brain perfusion a differentiating factor between Parkinson’s Disease (PD) and Progressive Supranuclear Palsy – Parkinsonism Predominant (PSP-P)?
-
Is Chronotype a biomarker for depression in military Veterans with Parkinson’s disease?
-
Is early-onset of levodopa-induced dyskinesia a predictor of GBA mutation? A next-generation sequencing study of young-onset Parkinson’s disease patients in Thailand
-
Is it time to consider circulating microRNAs as a diagnostic biomarker in REM sleep behavior disorder?
-
Is probable REM sleep behavior disorder a risk factor of impulsive-compulsive behaviors in Parkinson’s disease? PPMI study
-
Is the Montreal Cognitive Assessment (MoCA) Suitable for Identifying Mild Cognitive Impairment in Parkinson’s Disease?
-
Item Response Theory Analysis of the MDS-UPDRS Motor Examination: Tremor vs. Non-tremor Items
MDS Virtual Congress 2020
September 12-16, 2020. Virtual Congress. www.mdscongress.org